These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 3686768)

  • 1. Analysis of papillary renal adenocarcinoma.
    Mydlo JH; Bard RH
    Urology; 1987 Dec; 30(6):529-34. PubMed ID: 3686768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive subgroup analyses of survival outcomes between clear cell renal cell adenocarcinoma and papillary renal cell adenocarcinoma.
    Huang J; Huang D; Yan J; Chen T; Gao Y; Xu D; Na R
    Cancer Med; 2020 Dec; 9(24):9409-9418. PubMed ID: 33141518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histological subtyping and nuclear grading of renal cell carcinoma and their implications for survival: a retrospective nation-wide study of 629 patients.
    Gudbjartsson T; Hardarson S; Petursdottir V; Thoroddsen A; Magnusson J; Einarsson GV
    Eur Urol; 2005 Oct; 48(4):593-600. PubMed ID: 15964127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of extensive necrosis in renal cell carcinoma.
    Collins J; Epstein JI
    Hum Pathol; 2017 Aug; 66():108-114. PubMed ID: 28669641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal cell carcinoma with extensive clear cell change sharing characteristics of mucinous tubular and spindle cell carcinoma and papillary renal cell carcinoma.
    Kuroda N; Tamura M; Hes O; Michal M; Kawada C; Shuin T; Lee GH
    Pathol Int; 2009 Sep; 59(9):687-8. PubMed ID: 19712140
    [No Abstract]   [Full Text] [Related]  

  • 6. Papillary adenocarcinoma of kidney: a new perspective.
    Boczko S; Fromowitz FB; Bard RH
    Urology; 1979 Nov; 14(5):491-5. PubMed ID: 505701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term survival of patients with unilateral sporadic multifocal renal cell carcinoma according to histologic subtype compared with patients with solitary tumors after radical nephrectomy.
    Dimarco DS; Lohse CM; Zincke H; Cheville JC; Blute ML
    Urology; 2004 Sep; 64(3):462-7. PubMed ID: 15351571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negative impact of papillary histological subtype in patients with renal cell carcinoma extending into the inferior vena cava: single-center experience.
    Kondo T; Ikezawa E; Takagi T; Kobayashi H; Hashimoto Y; Iizuka J; Omae K; Yoshida K; Tanabe K
    Int J Urol; 2013 Nov; 20(11):1072-7. PubMed ID: 23421632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of 140 renal neoplasms. Survival evaluated on the basis of various parameters].
    Rizzello N; Carbone P; Milanese A; Lasaponara F
    Minerva Urol; 1981; 33(3):143-8. PubMed ID: 7322107
    [No Abstract]   [Full Text] [Related]  

  • 10. Outcome prediction for patients with renal cell carcinoma.
    Lohse CM; Gupta S; Cheville JC
    Semin Diagn Pathol; 2015 Mar; 32(2):172-83. PubMed ID: 25753528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clear cell papillary renal cell carcinoma and clear cell renal cell carcinoma arising in acquired cystic disease of the kidney: an immunohistochemical and genetic study.
    Kuroda N; Shiotsu T; Kawada C; Shuin T; Hes O; Michal M; Ohe C; Mikami S; Pan CC
    Ann Diagn Pathol; 2011 Aug; 15(4):282-5. PubMed ID: 20952286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression analysis of kidney-specific cadherin in a wide spectrum of traditional and newly recognized renal epithelial neoplasms: diagnostic and histogenetic implications.
    Kuehn A; Paner GP; Skinnider BF; Cohen C; Datta MW; Young AN; Srigley JR; Amin MB
    Am J Surg Pathol; 2007 Oct; 31(10):1528-33. PubMed ID: 17895753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Architectural Patterns are a Relevant Morphologic Grading System for Clear Cell Renal Cell Carcinoma Prognosis Assessment: Comparisons With WHO/ISUP Grade and Integrated Staging Systems.
    Verine J; Colin D; Nheb M; Prapotnich D; Ploussard G; Cathelineau X; Desgrandchamps F; Mongiat-Artus P; Feugeas JP
    Am J Surg Pathol; 2018 Apr; 42(4):423-441. PubMed ID: 29356723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Papillary renal cell carcinoma and tumor biology. A multicenter project with "tissue microarray" (TMA)].
    Herrmann E; Wülfing C; Hartmann A
    Urologe A; 2007 Sep; 46(9):1175-6. PubMed ID: 17646959
    [No Abstract]   [Full Text] [Related]  

  • 15. Pathologic features of renal cortical tumors.
    Tickoo SK; Gopalan A
    Urol Clin North Am; 2008 Nov; 35(4):551-61; v. PubMed ID: 18992609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Factors for Renal Cell Carcinoma Subtypes Diagnosed According to the 2016 WHO Renal Tumor Classification: a Study Involving 928 Patients.
    Kuthi L; Jenei A; Hajdu A; Németh I; Varga Z; Bajory Z; Pajor L; Iványi B
    Pathol Oncol Res; 2017 Jul; 23(3):689-698. PubMed ID: 28032311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal growth factor receptor and transforming growth factor alpha expression in papillary and nonpapillary renal cell carcinoma: correlation with metastatic behavior and prognosis.
    Uhlman DL; Nguyen P; Manivel JC; Zhang G; Hagen K; Fraley E; Aeppli D; Niehans GA
    Clin Cancer Res; 1995 Aug; 1(8):913-20. PubMed ID: 9816062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal cell carcinoma invading the urinary collecting system: implications for staging.
    Uzzo RG; Cherullo E; Myles J; Novick AC
    J Urol; 2002 Jun; 167(6):2392-6. PubMed ID: 11992044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphological subtyping of papillary renal cell carcinoma: clinicopathological characteristics and prognosis.
    Yamashita S; Ioritani N; Oikawa K; Aizawa M; Endoh M; Arai Y
    Int J Urol; 2007 Aug; 14(8):679-83. PubMed ID: 17681054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Renal cell carcinoma: pathological prognostic factors, staging and histopathological classification of 355 cases].
    Acosta-Jiménez E; Jerónimo-Guerrero D; Macías-Clavijo M; Rivera-Diez D; Hernández-Briseño L; Beltrán-Suárez E; Martínez-Olivares J; Ángeles-Garay U
    Rev Med Inst Mex Seguro Soc; 2015; 53(4):454-65. PubMed ID: 26177433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.